AI in industry / The AI briefing

Blue Cross Blue Shield analysis links hospital AI tools to increased healthcare spending

Hospitals using AI to process insurance claims added $942 million in costs over two years, according to a new analysis identifying a gap between medical coding and actual care.

Stethoscope and a calendar. Doctor's appointment and service in the hospital.
Image: TravelCouples / Getty Images. From TechCrunch AI. Image from the source publication.

An analysis by the Blue Cross Blue Shield Association indicates that hospitals using AI tools for insurance claims processing added $942 million in healthcare costs over two years. The study found a rise in documented complex patient conditions without a corresponding change in the actual medical care provided to those patients.

AI documentation and rising costs

The Blue Cross Blue Shield Association reported that hospital-side artificial intelligence tools contributed to nearly one billion dollars in extra spending. The analysis identified a significant increase in the documentation of complex patient conditions. However, the association observed a disconnect between these automated medical codes and the treatment patients received.

Researchers noted that while the AI systems identified more severe diagnostic codes, there was no evidence that the level of care delivered to patients changed accordingly. This suggests that the technology is currently used primarily to optimize billing rather than to reflect clinical outcomes or new treatment protocols.

Limitations of the association study

The findings represent the perspective of an insurance association during ongoing payment disputes with hospitals. While the analysis highlights a specific financial impact over a two-year period, it does not include data from hospital systems or independent clinical audits to verify the severity of the documented conditions.

Industry experts suggest that AI could eventually reduce tensions, yet the current data shows insurers struggling to keep pace with hospital-deployed agents. The study focuses on financial documentation rather than the underlying efficacy of the AI tools in a clinical setting.

Original source

This report summarises the source below. Analysis is labelled separately; product and research claims remain attributed to their source.

Read the original at TechCrunch AI

← Back to all AI news